FDA to Give Priority Review to Darzalex Combinations for Multiple Myeloma
The U.S. Food and Drug Admnistration will give…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
Researchers Find Faster, Better Approach to Harvesting Stem Cells for Bone Marrow Transplants, Mouse Study Suggests
A single injection of a new drug combination leads…
First Patient Dosed in Phase 1 Trial of P-BCMA-101 CAR T-Cell Therapy for Multiple Myeloma
The first patient has been dosed in a Phase…
Gamida Recruiting Myeloma Patients for Phase 1 Trial of Its Killer Cells-based Therapy
Gamida Cell is enrolling participants in a Phase 1…
Potential Myeloma Therapy Shows Positive Interim Phase 2 Trial Results, According to Report
Molecular Partners‘ multiple myeloma treatment candidate MP0250 showed positive…
Multiple Myeloma Patients Remain On Treatment Far Less than in Clinical Trials, Study Finds
Patients with relapsed or refractory multiple myeloma who are…
